The index of the Indonesian Stock Exchange (BEI) rose 145.12 points, or 2.89 percent, to 5,161.83, while the index of the 45 most liquid stocks (LQ45) increased 25.8 points, or 3.44 percent, to 805.12.
“PSBB is not so tight that the market is not worried. On the external front, the market has lauded the continued clinical trial of the COVID-19 vaccine by AstraZeneca,” Bina Artha Sekuritas analyst M. Nafan Aji Gusta Utama stated on Monday.
Another reason for the positive sentiment in the market is that US-China diplomatic relations have shown no signs of worsening, he added.
The market is also very enthusiastic as it awaits a US Federal Reserve announcement, in which it is expected to keep the benchmark interest rate unchanged at 0.25 percent on Thursday (September 17, 2020).
"In addition, optimism about Indonesia's economic recovery and trade surplus (has added to the sentiment)," he Utama noted.
After opening higher, the IHSG remained in the positive territory until the close of trade.
On a sectoral basis, the shares of all sectors rose, with the property sector recording the highest increase of 6.47 percent, followed by the basic industry at 4.29 percent, and the financial sector at 3.25 percent.
Net sales of foreign investors reached Rp648 billion in Monday's trade.
According to trade data, 734,570 transactions were recorded on Monday, with 14.24 billion shares worth Rp9.75 trillion changing hands. Meanwhile, 357 shares rose, 115 shares fell, and 135 shares remained unchanged.
In regional markets on Monday evening, the Nikkei Index climbed 152.81 points, or 0.65 percent, to 23,559.3; the Hang Seng Index jumped 136.97 points, or 0.56 percent, to 24,840.28; and, the Straits Times Index weakened 5.87 points, or 0.24 percent, to 2,484.22. (INE)
Related news: IHSG opens higher following fortnight re-imposition of PSBB in Jakarta
Related news: IHSG gains on PSBB re-imposition, COVID-19 vaccine optimism
EDITED BY INE